Literature DB >> 11390608

Identification of a novel transcriptional repressor encoded by human cytomegalovirus.

L A LaPierre1, B J Biegalke.   

Abstract

The expression of human cytomegalovirus (HCMV) genes during viral replication is precisely regulated, with the interactions of both transcriptional activators and repressors determining the level of gene expression. One gene of HCMV, the US3 gene, is transcriptionally repressed early in infection. Repression of US3 expression requires viral infection and protein synthesis and is mediated through a DNA sequence, the transcriptional repressive element. In this report, we identify the protein that represses US3 transcription as the product of the HCMV UL34 open reading frame. The protein encoded by UL34 (pUL34) binds to the US3 transcriptional repressive element in yeast and in vitro. pUL34 localizes to the nucleus and alone is sufficient for repression of US3 expression. The data presented here, along with earlier data (B. J. Biegalke, J. Virol. 72:5457-5463, 1998), suggests that pUL34 binding of the transcriptional repressive element prevents transcription initiation complex formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390608      PMCID: PMC114322          DOI: 10.1128/JVI.75.13.6062-6069.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Inhibition of the association of RNA polymerase II with the preinitiation complex by a viral transcriptional repressor.

Authors:  G Lee; J Wu; P Luu; P Ghazal; O Flores
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

2.  Cellular or viral protein binding to a cytomegalovirus promoter transcription initiation site: effects on transcription.

Authors:  M P Macias; L Huang; P E Lashmit; M F Stinski
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

Review 3.  Protein import into the nucleus: an integrated view.

Authors:  G R Hicks; N V Raikhel
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

4.  Repression of activator-mediated transcription by herpes simplex virus ICP4 via a mechanism involving interactions with the basal transcription factors TATA-binding protein and TFIIB.

Authors:  B Gu; R Kuddus; N A DeLuca
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

5.  Repression of the herpes simplex virus 1 alpha 4 gene by its gene product occurs within the context of the viral genome and is associated with all three identified cognate sites.

Authors:  N Michael; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

6.  Two distinct upstream regulatory domains containing multicopy cellular transcription factor binding sites provide basal repression and inducible enhancer characteristics to the immediate-early IES (US3) promoter from human cytomegalovirus.

Authors:  Y J Chan; W P Tseng; G S Hayward
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  Interaction of the viral activator protein ICP4 with TFIID through TAF250.

Authors:  M J Carrozza; N A DeLuca
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

8.  Regulation of a human cytomegalovirus immediate-early gene (US3) by a silencer-enhancer combination.

Authors:  A R Thrower; G C Bullock; J E Bissell; M F Stinski
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB.

Authors:  D Lang; S Gebert; H Arlt; T Stamminger
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Human cytomegalovirus immediate-early 2 (IE2) protein can transactivate the human hsp70 promoter by alleviation of Dr1-mediated repression.

Authors:  R Caswell; L Bryant; J Sinclair
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more
  9 in total

1.  Reevaluation of human cytomegalovirus coding potential.

Authors:  Eain Murphy; Isidore Rigoutsos; Tetsuo Shibuya; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-30       Impact factor: 11.205

2.  Characterization of the human cytomegalovirus UL34 gene.

Authors:  B J Biegalke; E Lester; A Branda; R Rana
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  The human cytomegalovirus UL35 gene encodes two proteins with different functions.

Authors:  Yingguang Liu; Bonita J Biegalke
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  UL34 Deletion Restricts Human Cytomegalovirus Capsid Formation and Maturation.

Authors:  Declan L Turner; Rachel M Templin; Adele A Barugahare; Brendan E Russ; Stephen J Turner; Georg Ramm; Rommel A Mathias
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

5.  Human cytomegalovirus UL34 binds to multiple sites within the viral genome.

Authors:  Ziqi Liu; Bonita J Biegalke
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

6.  Nontraditional localization and retention signals localize human cytomegalovirus pUL34 to the nucleus.

Authors:  Bonita J Biegalke
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

7.  Quantitative temporal viromics: an approach to investigate host-pathogen interaction.

Authors:  Michael P Weekes; Peter Tomasec; Edward L Huttlin; Ceri A Fielding; David Nusinow; Richard J Stanton; Eddie C Y Wang; Rebecca Aicheler; Isa Murrell; Gavin W G Wilkinson; Paul J Lehner; Steven P Gygi
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

8.  Mouse Cytomegalovirus M34 Encodes a Non-essential, Nuclear, Early-Late Expressed Protein Required for Efficient Viral Replication.

Authors:  Mareike Eilbrecht; Vu Thuy Khanh Le-Trilling; Mirko Trilling
Journal:  Front Cell Infect Microbiol       Date:  2020-05-05       Impact factor: 5.293

9.  Human cytomegalovirus UL34 early and late proteins are essential for viral replication.

Authors:  Rico Rana; Bonita J Biegalke
Journal:  Viruses       Date:  2014-01-28       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.